FDA Drug recall D-0852-2016
Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactu…
- FDA Drug
- Class II
- terminated
- Published 2016-05-18
On 2016-05-18 the FDA classified a Class II recall of Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactu… by Baxter Healthcare, citing discoloration: presence of atypical yellow discoloration of the solution .
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0852-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-04-12 |
| Published | 2016-05-18 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Baxter Healthcare |
| Distribution | US |
Product
Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87
Reason
Discoloration: presence of atypical yellow discoloration of the solution .
Identifiers
| ndc | 10019-115-39 |
|---|---|
| ndc | 10019-115-01 |
| ndc | 10019-075-87 |
| ndc | 10019-055-61 |
| code_info | Lot # C989954, Exp 9/17 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0852-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.